Loading...
CDCA8, targeted by MYBL2, promotes malignant progression and olaparib insensitivity in ovarian cancer
Ovarian cancer is the most lethal gynecologic malignancy. Poly (ADP-ribose) polymerase inhibitors (PARPi) are effective in treating ovarian cancer. However, cancer cell insensitivity and resistance remain challenges. Determination of the exact chemoresistance mechanisms and potential targeted therap...
Na minha lista:
| Udgivet i: | Am J Cancer Res |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
e-Century Publishing Corporation
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7868764/ https://ncbi.nlm.nih.gov/pubmed/33575078 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|